Porton Pharma Solutions Ltd.

Shenzhen Stock Exchange 300363.SZ

Porton Pharma Solutions Ltd. Goodwill for the year ending December 31, 2023: USD 41.03 M

Porton Pharma Solutions Ltd. Goodwill is USD 41.03 M for the year ending December 31, 2023, a -14.23% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.

Porton Pharma Solutions Ltd. Goodwill for the year ending December 31, 2022 was USD 47.84 M, a 8.39% change year over year.
Porton Pharma Solutions Ltd. Goodwill for the year ending December 31, 2021 was USD 44.13 M, a 19.20% change year over year.
Porton Pharma Solutions Ltd. Goodwill for the year ending December 31, 2020 was USD 37.02 M, a 3.71% change year over year.
Porton Pharma Solutions Ltd. Goodwill for the year ending December 31, 2019 was USD 35.70 M, a -0.54% change year over year.

Key data

Date	Goodwill	Total Assets	Current Liabilities	Total Non-Current Liabilities

Shenzhen Stock Exchange: 300363.SZ

Porton Pharma Solutions Ltd.

CEO	Mr. Nianfeng Ju
IPO Date	Jan. 29, 2014
Location	China
Headquarters	Fangzheng Avenue
Employees	4,915
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Porton Pharma Solutions Ltd. manufactures and supplies small molecule active pharmaceutical ingredients and drug intermediates, dosage forms, and biologics to the pharmaceutical companies. The company was formerly known as Porton Fine Chemicals Ltd. and changed its name to Porton Pharma Solutions Ltd. in January 2018. Porton Pharma Solutions Ltd. was founded in 2005 and is headquartered in Chongqing, China.

Key trends

Past 5 years